packageRibociclib

ribociclib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ribociclib is a protein kinase inhibitor used to treat breast cancer. It is an approved medicine, authorised in the European Union for breast cancer.

Summary written by glm-5.3-flash from Wikidata Q27088552 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ribociclib
ATC codes:L01EF02
DrugBank:DB11730
PubChem CID:44631912
Wikidata:Q27088552
formula:C23H30N8O
molar mass:434.548 g/mol (PubChem CID 44631912)
logP:2.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown